CSL Limited Share Price & Technical Analysis
CSLLY · $17.44 (+2.11%)
Healthcare / Biotechnology
$17.44
+2.11%
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produc…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
4% return in Jun, -2% avg return in past 3 year Jun month.
-45% return in 2026, -10% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 10% | -16% | -12% | -9% | -22% | 4% | – | – | – | – | – | – | -45% |
| 25 | -1% | -5% | -4% | 4% | -1% | -2% | 14% | -18% | 1% | -10% | 7% | -5% | -22% |
| 24 | 3% | -4% | 4% | -5% | 4% | 6% | 2% | 3% | -9% | -6% | -2% | -7% | -10% |
| 23 | 12% | -6% | -3% | 3% | -1% | -9% | -3% | -3% | -8% | -7% | 16% | 10% | 2% |
| 22 | -12% | 5% | 2% | -5% | 2% | -8% | 12% | -3% | -11% | -3% | 14% | -4% | -11% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$32.85B
P/E ratio
11.14
52W high
$44.85
52W low
$16.29
Volume
17,438
Beta
0.09
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is CSL Limited share price today?
- CSL Limited (CSLLY) last traded around $17.44 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CSLLY have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CSLLY. Download the app for real-time alerts.
- How can I analyze CSL Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.